Latest News
June 9, 2023
CAR-T hikes overall survival in relapsed/refractory LBCL
June 9, 2023
ASCO: American Society of Clinical Oncology
MDedge Hematology and Oncology
June 9, 2023
Widespread carboplatin, cisplatin shortages: NCCN survey
June 9, 2023
MDedge Hematology and Oncology
June 9, 2023
Cognitive decline risk in adult childhood cancer survivors
June 9, 2023
MDedge Hematology and Oncology
June 9, 2023
Is ChatGPT a friend or foe of medical publishing?
June 9, 2023
MDedge Hematology and Oncology
Conference Coverage
June 9, 2023
CAR-T hikes overall survival in relapsed/refractory LBCL
June 9, 2023
ASCO: American Society of Clinical Oncology
MDedge Hematology and Oncology
June 8, 2023
`Remarkable’: CAR T therapy for CLL/SLL
June 8, 2023
ASCO: American Society of Clinical Oncology
MDedge Hematology and Oncology
June 7, 2023
ER+/HER2– breast cancer: Is first or second line CDK4/6 inhibitor therapy better?
June 7, 2023
ASCO: American Society of Clinical Oncology
MDedge Hematology and Oncology
June 6, 2023
PMBCL: Postremission, patients may safely skip radiation
June 6, 2023
ASCO: American Society of Clinical Oncology
MDedge Hematology and Oncology
June 6, 2023
Metronomic chemotherapy performs well in second-line head and neck cancer
June 6, 2023
ASCO: American Society of Clinical Oncology
MDedge Hematology and Oncology
June 5, 2023
Antibody-drug conjugate changes standard of care for platinum-resistant ovarian cancer
June 5, 2023
ASCO: American Society of Clinical Oncology
MDedge Hematology and Oncology
Opinion
June 9, 2023
Did an unfair system help ADAURA win on overall survival?
June 9, 2023
MDedge Hematology and Oncology
June 7, 2023
How can we make medical training less ‘toxic’?
June 7, 2023
MDedge Hematology and Oncology
COVID-19 News
May 18, 2023
Review supports continued mask-wearing in health care visits
May 18, 2023
MDedge Hematology and Oncology
May 18, 2023
COVID emergency over, but hundreds are still dying weekly
May 18, 2023
MDedge Hematology and Oncology
March 21, 2023
COVID can mimic prostate cancer symptoms
March 21, 2023
MDedge Hematology and Oncology
March 10, 2023
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
March 10, 2023
ACC: American College of Cardiology
MDedge Hematology and Oncology
News from the FDA/CDC
June 1, 2023
Posluma approved for PET imaging in prostate cancer
June 1, 2023
MDedge Hematology and Oncology
May 9, 2023
New USPSTF draft suggests mammography start at 40, not 50
May 9, 2023
MDedge Hematology and Oncology
March 22, 2023
Prostate cancer drug shortage leaves some with uncertainty
March 22, 2023
MDedge Hematology and Oncology
Policy & Practice
June 9, 2023
Widespread carboplatin, cisplatin shortages: NCCN survey
June 9, 2023
MDedge Hematology and Oncology
June 9, 2023
Is ChatGPT a friend or foe of medical publishing?
June 9, 2023
MDedge Hematology and Oncology
June 8, 2023
When could you be sued for AI malpractice? You’re likely using it now
June 8, 2023
MDedge Hematology and Oncology
June 8, 2023
The enemy of carcinogenic fumes is my friendly begonia
June 8, 2023
MDedge Hematology and Oncology
Medicine’s Lighter Side
Livin' on the MDedge
June 8, 2023
The enemy of carcinogenic fumes is my friendly begonia
June 8, 2023
MDedge Hematology and Oncology
June 1, 2023
Ancient plague, cyclical pandemics … history lesson?
June 1, 2023
MDedge Hematology and Oncology
May 25, 2023
People still want their medical intelligence in human form
May 25, 2023
MDedge Hematology and Oncology
May 18, 2023
The antimicrobial peptide that even Pharma can love
May 18, 2023
MDedge Hematology and Oncology
Clinical Edge Journal Scan
May 24, 2023
Commentary: Pregnancy, neoadjuvant treatment, and sexual function after BC diagnosis, June 2023
May 24, 2023
MDedge Hematology and Oncology
April 26, 2023
Commentary: Endocrine therapy and mammography, May 2023
April 26, 2023
MDedge Hematology and Oncology
March 29, 2023
Commentary: Chemotherapies and gynecologic surgeries relative to breast cancer, April 2023
March 29, 2023
MDedge Hematology and Oncology
March 1, 2023
Commentary: Evaluating first-line regimens in breast cancer, March 2023
March 1, 2023
MDedge Hematology and Oncology